Brincidofovir API Manufacturer in India

Swapnroop Pharma · WHO-GMP Certified · +91 87670 62101

Brincidofovir API

Brincidofovir is an orally bioavailable lipid-conjugated prodrug of cidofovir and an antiviral active pharmaceutical ingredient. It is also known as CMX001, HDP-cidofovir, and hexadecyloxypropyl-cidofovir. Its CAS number is 444805-28-1, with molecular formula C₂₇H₅₂N₃O₇P and molecular weight 561.69 g/mol.

Brincidofovir is a nucleotide analogue antiviral that is converted intracellularly to cidofovir and subsequently to the active metabolite cidofovir diphosphate. The FDA-approved product TEMBEXA is indicated for treatment of human smallpox disease.

Key Characteristics

  • Chemical Name: Phosphonic acid, P-[[(1S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]-, mono[3-(hexadecyloxy)propyl] ester
  • CAS Number: 444805-28-1
  • Molecular Formula: C₂₇H₅₂N₃O₇P
  • Molecular Weight: 561.69 g/mol
  • Appearance: White to off-white crystalline powder
  • Form: Powder
  • Water Solubility: Practically insoluble
  • DMSO Solubility: 2 mg/mL, clear when warmed, for the cited research-grade material
  • Synonyms: CMX001, CMX-001, HDP-Cidofovir, Hexadecyloxypropyl-cidofovir
  • ATC Code: J05AB17

Detailed Specifications

Parameter Specification
Appearance White to off-white crystalline powder
Identification IR & HPLC
Assay (HPLC) ≥ 98.0%
Solubility Practically insoluble in water; soluble in DMSO with warming
Get Bulk Quote via WhatsApp